GWLL
GOLDENWELL BIOTECH, INC.
Key Financials
Revenue
$139
↓ 92.4%
Operating Income
$-123098
↓ 5.3%
Net Income
$-131498
↓ 12.5%
EPS (Diluted)
$0.00
NaN%
Gross Profit
$64
↓ 94.2%
Total Liabilities
$271433.00
↑ 89.4%
Shareholders' Equity
$-47241.00
↓ 155.8%
Total Assets
$224192.00
↓ 1.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GWLL |
| Company Name | GOLDENWELL BIOTECH, INC. |
| CIK | 1800373 |
| SIC Code | 2000 |
| SIC Description | Food and Kindred Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 440-666-7999 |